Nourkrin®

The Nourkrin® Effect

In tests, where 3,000 Nourkrin® users were surveyed, 83% of respondents reported a significant improvement in their hair growth after taking Nourkrin® for 12 months.

Nourkrin®’s market leader status is the result of more than 100 scientific studies and clinical papers, as well as multiple user studies published in leading peer-reviewed journals over the last 30 years. Nourkrin® is completely drug-free and based on natural ingredients.

Nourkrin® with Marilex® works in conjunction with the normal duration of the Hair Growth Cycle, and this is why Nourkrin® should be taken for a minimum of 4 to 6 months.

Nourkrin® with the unique, proprietary Marilex® is a scientifically developed bioactive proteoglycan formula formulated to support normal, healthy hair growth by addressing Proteoglycan Follicular Atrophy, which is an underlying cause of almost all cases of hair growth disruption, no matter the cause or type.

YES, IT WORKS!

Nourkrin® is scientifically proven – read more

62,5% after 2 months

70% after 6 months

83% after 12 months

NATURAL, SAFE AND
SCIENTIFICALLY PROVEN

Nourkrin® with Marilex® has helped hundreds of thousands of women and men to restore a healthy Hair Growth Cycle and is recognised by scientists, doctors, dermatologists, and trichologists worldwide.

Nourkrin® is supported by 30 years of clinical development and has consistently provided the original hair growth efficacy that consumers trust and rely upon. Nourkrin® is the only product worldwide containing Marilex®, a naturally derived and active ingredient, with a unique and protected composition structure containing the specific proteoglycans that play an integral role in healthy hair growth regulation.

Hair loss and hair growth disruptions can in most cases be explained by a ‘lower than normal’ concentration of proteoglycans that causes follicular degradation – this is known as Proteoglycan Follicular Atrophy. Proteoglycan Replacement Therapy, i.e., Nourkrin® with Marilex®, is a clinically documented, first-line therapy proven to be clinically effective in 9 out of 10 women suffering from Proteoglycan Follicular Atrophy.